$27.25
-0.240 (-0.87%)
At Close: Jun 03, 2026
5 Low-Leverage Stocks to Buy Amid Trump's Tariff Woes
08:30am, Monday, 24'th Mar 2025
The majority of U.S. stock indices ended barely in the green on March 21, 2025, overcoming their recent losing streaks since investors remain wary about the long-term economic impacts of President Tru
BioLife Solutions Appoints Cathy Coste as Director and Audit Committee Chair
08:30am, Tuesday, 18'th Mar 2025
BOTHELL, Wash. , March 18, 2025 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS ) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cel
5 Low-Leverage Stocks to Buy Amid Volatile Market Sentiment
11:00am, Monday, 10'th Mar 2025
The crux of safe investment lies in choosing a company that is not burdened with debt. You may buy BLFS, BHLB, NVDA, GBX and EZPW.
BioLife Solutions, Inc. (BLFS) Reports Q4 Loss, Tops Revenue Estimates
09:10am, Monday, 03'rd Mar 2025
BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.30 per share a year ago.
BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results
07:00am, Monday, 03'rd Mar 2025
Cell Processing revenue up 7% sequentially to $20.3 million in the fourth quarter; 2024 Cell Processing revenue up 12% over prior year to $73.5 million GAAP gross margin of 60% and non-GAAP adju
BioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025
04:03pm, Thursday, 20'th Feb 2025
BOTHELL, Wash. , Feb. 20, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") mar
Recent Price Trend in BioLife Solutions (BLFS) is Your Friend, Here's Why
09:51am, Wednesday, 12'th Feb 2025
BioLife Solutions (BLFS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thro
BioLife Solutions, Inc. (BLFS) Hit a 52 Week High, Can the Run Continue?
10:16am, Wednesday, 29'th Jan 2025
BioLife Solutions (BLFS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year?
10:41am, Friday, 24'th Jan 2025
Here is how BioLife Solutions, Inc. (BLFS) and Ginkgo Bioworks Holdings, Inc. (DNA) have performed compared to their sector so far this year.
BioLife Solutions (BLFS) Is a Great Choice for 'Trend' Investors, Here's Why
09:50am, Wednesday, 22'nd Jan 2025
If you are looking for stocks that are well positioned to maintain their recent uptrend, BioLife Solutions (BLFS) could be a great choice. It is one of the several stocks that passed through our "Rece
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations
08:30am, Monday, 13'th Jan 2025
Fourth quarter Cell Processing revenue increased 7% sequentially to $20.3 million Unaudited revenue for FY2024 from Cell Processing of $73.5 million, exceeded the high end of previously raised guidanc
BioLife Solutions price target raised to $31 from $28 at Northland
08:43am, Wednesday, 08'th Jan 2025
Northland raised the firm's price target on BioLife Solutions to $31 from $28 and keeps an Outperform rating on the shares. With the divestiture of its freezer businesses and the recent sale of SciSaf
BioLife Solutions Appoints Tony J. Hunt to its Board of Directors
08:11am, Monday, 16'th Dec 2024
BOTHELL, Wash. , Dec. 16, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS ) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell
BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary
04:05pm, Thursday, 14'th Nov 2024
Completes the Company's strategic move away from capital equipment businesses BOTHELL, Wash. , Nov. 14, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a
BioLife Solutions, Inc. (BLFS) Q3 2024 Earnings Call Transcript
08:41pm, Tuesday, 12'th Nov 2024
BioLife Solutions, Inc. (NASDAQ:BLFS ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Troy Wichterman - Chief Financial Officer Rod de Greef - Chairman and Chief Ex
Sign In
Buy BLFS